Nuvectis Pharma Stock Market Value
| NVCT Stock | USD 4.95 0.15 2.94% |
| Symbol | Nuvectis |
Nuvectis Pharma Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nuvectis Pharma. If investors know Nuvectis will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Nuvectis Pharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.16) | Return On Assets (0.61) | Return On Equity (1.40) |
The market value of Nuvectis Pharma is measured differently than its book value, which is the value of Nuvectis that is recorded on the company's balance sheet. Investors also form their own opinion of Nuvectis Pharma's value that differs from its market value or its book value, called intrinsic value, which is Nuvectis Pharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nuvectis Pharma's market value can be influenced by many factors that don't directly affect Nuvectis Pharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Nuvectis Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Nuvectis Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nuvectis Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Nuvectis Pharma 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Nuvectis Pharma's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Nuvectis Pharma.
| 10/27/2024 |
| 11/26/2024 |
If you would invest 0.00 in Nuvectis Pharma on October 27, 2024 and sell it all today you would earn a total of 0.00 from holding Nuvectis Pharma or generate 0.0% return on investment in Nuvectis Pharma over 30 days. Nuvectis Pharma is related to or competes with Replimune, Lyra Therapeutics, Kronos Bio, Gossamer Bio, Olema Pharmaceuticals, Larimar Therapeutics, and Centessa Pharmaceuticals. Nuvectis Pharma, Inc., a biopharmaceutical company, focuses on the development of precision medicines for the treatment ... More
Nuvectis Pharma Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Nuvectis Pharma's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Nuvectis Pharma upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.03) | |||
| Maximum Drawdown | 75.91 | |||
| Value At Risk | (10.50) | |||
| Potential Upside | 10.84 |
Nuvectis Pharma Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Nuvectis Pharma's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Nuvectis Pharma's standard deviation. In reality, there are many statistical measures that can use Nuvectis Pharma historical prices to predict the future Nuvectis Pharma's volatility.| Risk Adjusted Performance | (0.0005) | |||
| Jensen Alpha | (0.46) | |||
| Total Risk Alpha | (1.44) | |||
| Treynor Ratio | (0.04) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Nuvectis Pharma's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Nuvectis Pharma Backtested Returns
Nuvectis Pharma has Sharpe Ratio of -0.0137, which conveys that the firm had a -0.0137% return per unit of risk over the last 3 months. Nuvectis Pharma exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify Nuvectis Pharma's Mean Deviation of 4.31, risk adjusted performance of (0.0005), and Standard Deviation of 8.43 to check out the risk estimate we provide. The company secures a Beta (Market Risk) of 2.87, which conveys a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Nuvectis Pharma will likely underperform. At this point, Nuvectis Pharma has a negative expected return of -0.12%. Please make sure to verify Nuvectis Pharma's value at risk, daily balance of power, as well as the relationship between the Daily Balance Of Power and period momentum indicator , to decide if Nuvectis Pharma performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.12 |
Insignificant reverse predictability
Nuvectis Pharma has insignificant reverse predictability. Overlapping area represents the amount of predictability between Nuvectis Pharma time series from 27th of October 2024 to 11th of November 2024 and 11th of November 2024 to 26th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Nuvectis Pharma price movement. The serial correlation of -0.12 indicates that less than 12.0% of current Nuvectis Pharma price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.12 | |
| Spearman Rank Test | -0.69 | |
| Residual Average | 0.0 | |
| Price Variance | 6.52 |
Nuvectis Pharma lagged returns against current returns
Autocorrelation, which is Nuvectis Pharma stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Nuvectis Pharma's stock expected returns. We can calculate the autocorrelation of Nuvectis Pharma returns to help us make a trade decision. For example, suppose you find that Nuvectis Pharma has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Nuvectis Pharma regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Nuvectis Pharma stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Nuvectis Pharma stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Nuvectis Pharma stock over time.
Current vs Lagged Prices |
| Timeline |
Nuvectis Pharma Lagged Returns
When evaluating Nuvectis Pharma's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Nuvectis Pharma stock have on its future price. Nuvectis Pharma autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Nuvectis Pharma autocorrelation shows the relationship between Nuvectis Pharma stock current value and its past values and can show if there is a momentum factor associated with investing in Nuvectis Pharma.
Regressed Prices |
| Timeline |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Nuvectis Stock Analysis
When running Nuvectis Pharma's price analysis, check to measure Nuvectis Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nuvectis Pharma is operating at the current time. Most of Nuvectis Pharma's value examination focuses on studying past and present price action to predict the probability of Nuvectis Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nuvectis Pharma's price. Additionally, you may evaluate how the addition of Nuvectis Pharma to your portfolios can decrease your overall portfolio volatility.